Month: August 2024

– Positive data from ongoing Phase 1/1b clinical trial of WTX-124 presented at American Society of Clinical Oncology (ASCO) Annual Meeting...

The Company Also Announces the Opening of a New Canna Cabana Store in Belleville, Ontario CALGARY, AB, Aug. 8, 2024...

Q2 2024 Revenues Surpassed Guidance while Gross Margin and EPS In Line With Guidance Range Issued on May 9, 2024Company...

- Entered into Definitive Merger Agreement to be Acquired by Pharmacosmos; Transaction Expected to Close in Late Third Quarter 2024...

SAN MATEO, Calif., Aug. 8, 2024 /PRNewswire/ -- GoPro, Inc. (NASDAQ: GPRO) today announced that Founder and Chief Executive Officer Nicholas...

CHICAGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace...

IND clearance achieved for MRT-6160, a VAV1-directed MGD in development for systemic and neurological autoimmune diseases; on track to initiate...

Revenue Increased by 13% Year-over-Year,GAAP Operating Income of $2.8 Million andAdjusted EBITDA of $10.1 MillionRead more at globenewswire.com

U.S. commercial launch of RYTELO™ (imetelstat) began in June 2024 for patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia...

Contacts Investor Contact GoodRx Aubrey Reynolds ir@goodrx.com Press Contact GoodRx Lauren Casparis lcasparis@goodrx.com GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us,"...

AUSTIN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software...

Q2 2024 Total Revenue of $126.7M, a 34% Increase Year-over-YearGalafold® Q2 Revenue of $110.8M, up 17% Year-over-YearRead more at globenewswire.com

Topline Phase 1 dose escalation data for FHD-286 in combination with decitabine, in relapsed and/or refractory AML patients, anticipated in...

Second Quarter 2024 Highlights1Reaffirming Standalone First Advantage Full-Year 2024 GuidanceRead more at globenewswire.com

WATERTOWN, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing...

NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic company with two FDA-approved products and...

Contacts Investor: investor.relations@nationalvision.com National Vision Holdings, Inc. Tamara Gonzalez ICR, Inc. Caitlin Churchill Media: media@nationalvision.com National Vision Holdings, Inc. Racheal...

Anfield deploys Wi-Fi to help drive more engaging digital fan experiences and streamline stadium operations Contacts Media Blair Donald (603)...

Key scientific achievement advances the joint neuroscience pipeline and earns a payment of US$ 25 m to Evotec to progress...

SAN FRANCISCO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...

HAIFA, Israel, Aug. 8, 2024 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced...

AUSTIN, Texas, Aug. 7, 2024 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced...

Q2 2024 and Recent Highlights NEW YORK, Aug. 8, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a...

Second quarter Net Revenue grows 7.3%, Organic Revenue increases 7.8% Updated 2024 guidance reflects sale of majority stake in Insomnia...

CRANFORD, N.J., Aug. 8, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) ("Citius", "Citius Pharma"), announced today that the U.S....

BERKELEY HEIGHTS, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...

Second Quarter Highlights Consolidated net sales of $1.39 billion Core net sales of $1.05 billion* GAAP income from continuing operations...

Key Q2 2024 HighlightsFLORHAM PARK, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Conduent (NASDAQ: CNDT), a global technology-led business process...

BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...

HONG KONG, Aug. 7, 2024 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS) today announced that, through its...

SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its...

- Proof-of-Concept Phase 2 SHINE Trial Demonstrates ~40% Mean Improvement in ADAS-Cog 11 vs Placebo and Consistent Positive Changes Across...

No Shareholder Action Required at This Time Contacts Investor Relations Contact: Rob Fink FNK IR on behalf of Cognyte Software...

Investigational New Drug (IND) application for CLN-978 in systemic lupus erythematosus (SLE) remains on track to be filed in third...

MINNEAPOLIS, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...

Financial and Business Highlights WASHINGTON, Aug. 8, 2024 /PRNewswire/ -- Cogent Communications Holdings, Inc. (NASDAQ: CCOI) ("Cogent") today announced service...

SOMERSET, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare...

SOMERSET, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare...